Drug Eluting Stents for Very Long Lesions: Go Long, But Know the Risks
- PMID: 28488403
- DOI: 10.1002/ccd.27073
Drug Eluting Stents for Very Long Lesions: Go Long, But Know the Risks
Abstract
Long coronary artery lesions are increasingly treated with new technologies including current generation drug eluting stents (DES) despite a lack of robust data on outcomes. In the current study, patients receiving Xience V DES for very long lesions (>35 mm) compared to lesions 25-35 mm had similar outcomes. Future research should address late outcomes, stent thrombosis rates, as well as investigation of lesions greater than 60 mm.
© 2017 Wiley Periodicals, Inc.
Comment on
-
Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.Catheter Cardiovasc Interv. 2017 May;89(6):984-991. doi: 10.1002/ccd.26711. Epub 2016 Aug 22. Catheter Cardiovasc Interv. 2017. PMID: 27545721
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
